Cue the cutaneous preemptive strike.

Did you know prophylactic doxycycline, topical corticosteroids, moisturizers, and sunscreen can slash cutaneous toxicity with EGFR-inhibitors like cetuximab, thereby improving compliance among the very people who benefit most? This look back at outcomes at Dana Farber reports such early interventions rendered patients 79% less likely to require a cetuximab dose reduction or interruption. | Yu, JAMA Dermatol 2020